Prebiotic xylooligosaccharides ameliorate metabolic dysfunction-associated steatotic liver disease via modulating gut microbiota and metabolites
Abstract The study investigated the dose-dependent protective effects of xylooligosaccharides (XOS) against metabolic dysfunction-associated steatotic liver disease (MASLD) in mice, focusing on gut microbiota and microbial metabolites. Male C57BL/6 mice were fed either a low-fat diet(LFD), a high-fa...
Na minha lista:
| Principais autores: | , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Nature Portfolio
2026-04-01
|
| coleção: | Scientific Reports |
| Assuntos: | |
| Acesso em linha: | https://doi.org/10.1038/s41598-026-48643-8 |
| Tags: |
Sem tags, seja o primeiro a adicionar uma tag!
|